Alternative beta is increasingly gaining traction among institutional investors and is particularly relevant to mitigate current equity-related risks. Chris Stevens, senior associate at London-based financial advisor bfinance, explains why.
Cookies on Insurance Asset Risk
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here